NasdaqGS:GILDBiotechs
Gilead Sciences (GILD) Net Margin Reset Challenges Slower Growth Narratives In FY 2025 Results
Gilead Sciences FY 2025 earnings snapshot
Gilead Sciences (GILD) has wrapped up FY 2025 with fourth quarter revenue of US$7.9b and basic EPS of US$1.76, alongside trailing 12 month revenue of US$29.4b and EPS of US$6.84 as the company reports a fuller picture of its year.
Over the past year, quarterly revenue has ranged from US$6.7b in Q1 2025 to US$7.9b in Q4 2025, while basic EPS has moved between US$1.06 and US$2.46 across those quarters, backing trailing 12 month net income of US$8.5b and...